Next Plant-Based Unicorn

From MicroSmallCap | Ad

The plant-based industry has been ignited. Pay close attention to this stock.

Learn more.

UTHR Insider Trading (United Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,154,688.72

United Therapeutics Insider Trading History Chart

United Therapeutics Share Price & Price History

^$180.66

▲ +0.8 (0.44%)

As of 08/3/2021 01:00 AM ET

Days: 30 | 90 | 365

Even Utah Is Falling in Love with Psychedelics

From Investing Trends | Ad

Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.

Here's how you could get in on the ground floor

United Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2021	Christopher Patusky	Director	Sell	100	$190.52	$19,052.00	4,800
4/1/2021	Judy D Olian	Director	Sell	4,207	$184.96	$778,126.72	9,997
3/17/2021	Judy D Olian	Director	Sell	2,103	$170.00	$357,510.00	7,893
7/8/2020	Martine A Rothblatt	CEO	Sell	10,000	$117.91	$1,179,100.00	10,140
7/6/2020	Martine A Rothblatt	CEO	Sell	10,000	$119.60	$1,196,000.00	10,140
7/2/2020	Martine A Rothblatt	CEO	Sell	10,000	$120.73	$1,207,300.00	10,140
6/30/2020	Martine A Rothblatt	CEO	Sell	10,000	$120.36	$1,203,600.00	10,140
6/29/2020	Raymond Dwek	Director	Sell	4,600	$116.81	$537,326.00	4,600
6/26/2020	Martine A Rothblatt	CEO	Sell	10,000	$121.00	$1,210,000.00	10,140
6/24/2020	Martine A Rothblatt	CEO	Sell	30,000	$119.54	$3,586,200.00	10,140
6/22/2020	Martine A Rothblatt	CEO	Sell	10,000	$117.81	$1,178,100.00	10,140
6/19/2020	Martine A Rothblatt	CEO	Sell	20,000	$116.35	$2,327,000.00	10,140
6/17/2020	Martine A Rothblatt	CEO	Sell	10,000	$117.82	$1,178,200.00	10,140
6/15/2020	Martine A Rothblatt	CEO	Sell	10,000	$113.87	$1,138,700.00	10,140
6/12/2020	Martine A Rothblatt	CEO	Sell	20,000	$115.42	$2,308,400.00	10,140
6/10/2020	Martine A Rothblatt	CEO	Sell	30,000	$122.86	$3,685,800.00	10,140
6/8/2020	Judy D Olian	Director	Sell	4,510	$124.96	$563,569.60	3,490
6/5/2020	Martine A Rothblatt	CEO	Sell	10,000	$123.59	$1,235,900.00	10,140
6/3/2020	Martine A Rothblatt	CEO	Sell	10,000	$124.52	$1,245,200.00	10,140
6/1/2020	Martine A Rothblatt	CEO	Sell	10,000	$119.28	$1,192,800.00	10,140
5/29/2020	Martine A Rothblatt	CEO	Sell	10,000	$115.91	$1,159,100.00	10,140
5/27/2020	Martine A Rothblatt	CEO	Sell	10,000	$115.90	$1,159,000.00	10,140
5/5/2020	Tommy G Thompson	Director	Sell	3,100	$112.56	$348,936.00	9,050
4/20/2020	Richard Giltner	Director	Sell	5,000	$107.00	$535,000.00	8,750
4/14/2020	Richard Giltner	Director	Sell	5,000	$99.00	$495,000.00	8,750
3/26/2020	Richard Giltner	Director	Sell	5,000	$91.75	$458,750.00	8,750
6/27/2019	Raymond Dwek	Director	Sell	3,750	$76.11	$285,412.50	3,750
6/20/2019	Richard Giltner	Director	Sell	5,000	$79.05	$395,250.00	5,000
3/7/2019	Christopher Patusky	Director	Sell	3,370	$110.75	$373,227.50
2/5/2019	Tommy G Thompson	Director	Sell	400	$117.00	$46,800.00	2,970
1/30/2019	Martine A Rothblatt	CEO	Sell	14,108	$115.77	$1,633,283.16	7,194
1/28/2019	Martine A Rothblatt	CEO	Sell	14,108	$115.37	$1,627,639.96	7,194
1/24/2019	Martine A Rothblatt	CEO	Sell	7,054	$113.95	$803,803.30	7,194
1/22/2019	Martine A Rothblatt	CEO	Sell	7,054	$113.35	$799,570.90	7,194
1/17/2019	Martine A Rothblatt	CEO	Sell	14,108	$113.70	$1,604,079.60	7,194
1/15/2019	Martine A Rothblatt	CEO	Sell	14,108	$114.85	$1,620,303.80	7,194
1/10/2019	Martine A Rothblatt	CEO	Sell	14,108	$113.51	$1,601,399.08	7,194
1/8/2019	Martine A Rothblatt	CEO	Sell	7,054	$113.16	$798,230.64	7,195
1/4/2019	Martine A Rothblatt	CEO	Sell	7,055	$111.51	$786,703.05	1,540
9/10/2018	Christopher Causey	Director	Sell	810	$119.00	$96,390.00	1,555
9/6/2018	Christopher Causey	Director	Sell	810	$118.00	$95,580.00	3,925
8/16/2018	Richard Giltner	Director	Sell	3,240	$129.38	$419,191.20
8/3/2018	Christopher Causey	Director	Sell	580	$127.48	$73,938.40	1,605

Insider Buying at United Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for United Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for United Therapeutics (NASDAQ:UTHR)

94.99% of United Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

United Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/3/2021	MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income	12,230	$2.19M	0.2%	-78.3%	0.027%
8/3/2021	Handelsbanken Fonder AB	7,500	$1.35M	0.0%	-9.6%	0.017%
8/3/2021	Cookson Peirce & Co. Inc.	3,145	$0.56M	0.0%	+6.9%	0.007%
8/3/2021	Victory Capital Management Inc.	13,335	$2.39M	0.0%	-12.0%	0.030%
8/3/2021	Hussman Strategic Advisors Inc.	7,200	$1.29M	0.3%	-33.3%	0.016%
8/3/2021	Oppenheimer & Co. Inc.	2,860	$0.51M	0.0%	-7.0%	0.006%
8/3/2021	Oppenheimer Asset Management Inc.	34,595	$6.21M	0.1%	N/A	0.077%
8/3/2021	Poplar Forest Capital LLC	177,141	$31.78M	3.1%	+11,154.2%	0.395%
8/2/2021	Arizona State Retirement System	12,108	$2.17M	0.0%	-6.4%	0.027%
8/2/2021	New York State Common Retirement Fund	92,097	$16.52M	0.0%	+3.9%	0.206%
8/2/2021	Advisor Group Holdings Inc.	3,051	$0.55M	0.0%	+5.6%	0.007%
8/2/2021	Clark Capital Management Group Inc.	18,522	$3.32M	0.0%	+16.3%	0.041%
8/2/2021	Sumitomo Mitsui Trust Holdings Inc.	1,900	$0.34M	0.0%	-42.4%	0.004%
8/1/2021	Dupont Capital Management Corp	4,339	$0.78M	0.0%	-31.0%	0.010%
8/1/2021	Exchange Traded Concepts LLC	2,944	$0.53M	0.0%	-5.0%	0.007%
8/1/2021	Zurcher Kantonalbank Zurich Cantonalbank	5,888	$1.06M	0.0%	+8.1%	0.013%
7/31/2021	Emerald Mutual Fund Advisers Trust	184,289	$33.06M	1.1%	-1.2%	0.411%
7/31/2021	Unigestion Holding SA	4,773	$0.85M	0.0%	+30.7%	0.011%
7/31/2021	Advisors Asset Management Inc.	2,472	$0.44M	0.0%	+45.6%	0.006%
7/31/2021	State of Michigan Retirement System	11,293	$2.03M	0.0%	-31.5%	0.025%
7/31/2021	Texas Permanent School Fund	33,383	$5.99M	0.1%	+0.3%	0.075%
7/31/2021	Chartwell Investment Partners LLC	27,119	$4.87M	0.1%	+10.5%	0.061%
7/31/2021	Cutler Group LP	400	$71K	0.0%	-90.9%	0.001%
7/31/2021	Eagle Health Investments LP	98,038	$17.59M	6.0%	+127.5%	0.219%
7/31/2021	Veriti Management LLC	1,201	$0.22M	0.0%	N/A	0.003%
7/30/2021	Alliancebernstein L.P.	71,425	$12.81M	0.0%	-1.5%	0.159%
7/29/2021	Emerald Advisers LLC	187,460	$33.63M	1.2%	-3.6%	0.418%
7/27/2021	Clean Yield Group	150	$27K	0.0%	N/A	0.000%
7/23/2021	Oregon Public Employees Retirement Fund	15,276	$2.74M	0.0%	+3.0%	0.034%
7/15/2021	New England Research & Management Inc.	1,125	$0.20M	0.1%	-65.4%	0.003%
7/15/2021	Pflug Koory LLC	525	$94K	0.0%	N/A	0.001%
7/15/2021	Cardinal Capital Management	6,801	$1.22M	0.3%	+1.4%	0.015%
7/13/2021	New Mexico Educational Retirement Board	9,200	$1.65M	0.1%	+17.9%	0.021%
7/12/2021	State of Alaska Department of Revenue	16,309	$2.93M	0.0%	-10.0%	0.036%
5/28/2021	Schroder Investment Management Group	55,096	$9.22M	0.0%	-50.5%	0.123%
5/24/2021	Principal Financial Group Inc.	153,074	$25.61M	0.0%	+16.4%	0.342%
5/22/2021	Teachers Retirement System of The State of Kentucky	7,029	$1.18M	0.0%	-9.1%	0.016%
5/21/2021	Stonnington Group LLC	3,900	$0.76M	0.2%	N/A	0.009%
5/19/2021	Virtu Financial LLC	2,584	$0.43M	0.0%	N/A	0.006%
5/19/2021	Squarepoint Ops LLC	27,321	$4.57M	0.0%	+116.1%	0.061%
5/18/2021	Paloma Partners Management Co	11,140	$1.86M	0.0%	N/A	0.025%
5/18/2021	Scopia Capital Management LP	209,285	$35.01M	4.3%	+1.8%	0.467%
5/18/2021	Utah Retirement Systems	8,346	$1.40M	0.0%	-3.5%	0.019%
5/18/2021	First Light Asset Management LLC	2,466	$0.41M	0.0%	N/A	0.006%
5/18/2021	Capital Impact Advisors LLC	17,638	$2.95M	1.0%	-7.3%	0.039%
5/18/2021	D. E. Shaw & Co. Inc.	373,462	$62.47M	0.1%	-22.9%	0.834%
5/18/2021	Eaton Vance Management	177	$30K	0.0%	N/A	0.000%
5/18/2021	Amundi Asset Management US Inc.	3,008	$0.50M	0.0%	N/A	0.007%
5/18/2021	Loomis Sayles & Co. L P	76,073	$12.73M	0.0%	-7.0%	0.170%
5/18/2021	State of Wisconsin Investment Board	5,504	$0.92M	0.0%	-1.5%	0.012%
5/18/2021	Morgan Stanley	37,644	$6.30M	0.0%	-18.2%	0.084%
5/18/2021	Maverick Capital Ltd.	7,514	$1.26M	0.0%	N/A	0.017%
5/18/2021	Great Point Partners LLC	156,406	$26.16M	5.4%	+4.3%	0.349%
5/18/2021	Cubist Systematic Strategies LLC	6,893	$1.15M	0.0%	+50.8%	0.015%
5/18/2021	Krensavage Asset Management LLC	249,421	$41.72M	14.4%	-22.7%	0.557%
5/18/2021	Gotham Asset Management LLC	19,164	$3.21M	0.1%	+65.0%	0.043%
5/18/2021	Man Group plc	83,957	$14.04M	0.1%	-18.7%	0.187%
5/18/2021	California State Teachers Retirement System	75,679	$12.66M	0.0%	-0.4%	0.169%
5/18/2021	Ameritas Investment Company LLC	1,494	$0.25M	0.0%	N/A	0.003%
5/17/2021	Schonfeld Strategic Advisors LLC	13,500	$2.26M	0.0%	N/A	0.030%
5/17/2021	Palo Alto Investors LP	687,206	$114.95M	6.5%	-12.5%	1.534%
5/17/2021	Perceptive Advisors LLC	175,000	$29.27M	0.4%	N/A	0.391%
5/17/2021	BCJ Capital Management LLC	3,460	$0.58M	0.1%	N/A	0.008%
5/17/2021	Great West Life Assurance Co. Can	21,804	$3.64M	0.0%	-7.3%	0.049%
5/17/2021	Point72 Hong Kong Ltd	3,734	$0.63M	0.0%	N/A	0.008%
5/17/2021	AQR Capital Management LLC	627,267	$104.92M	0.2%	+0.5%	1.400%
5/17/2021	Virtus ETF Advisers LLC	4,376	$0.73M	0.3%	+2.9%	0.010%
5/17/2021	Royal Bank of Canada	18,966	$3.17M	0.0%	-3.6%	0.042%
5/17/2021	Polar Capital Holdings Plc	8,474	$1.42M	0.0%	+158.1%	0.019%
5/17/2021	Putnam Investments LLC	50,559	$8.46M	0.0%	N/A	0.113%
5/17/2021	Price T Rowe Associates Inc. MD	354,124	$59.23M	0.0%	+45.4%	0.791%
5/17/2021	Captrust Financial Advisors	3,087	$0.52M	0.0%	+39.7%	0.007%
5/17/2021	Clark Capital Management Group Inc.	15,930	$2.67M	0.0%	-32.0%	0.036%
5/17/2021	Summit Street Capital Management LLC	37,805	$6.32M	4.1%	-7.9%	0.084%
5/17/2021	Janus Henderson Group PLC	12,691	$2.12M	0.0%	-32.4%	0.028%
5/17/2021	Ameriprise Financial Inc.	156,081	$26.11M	0.0%	-13.2%	0.348%
5/17/2021	Hennion & Walsh Asset Management Inc.	38,072	$6.37M	0.4%	N/A	0.085%
5/17/2021	Nomura Holdings Inc.	6,250	$1.05M	0.0%	N/A	0.014%
5/17/2021	HRT Financial LP	5,963	$1M	0.0%	N/A	0.013%
5/17/2021	Quantitative Investment Management LLC	2,017	$0.34M	0.0%	-63.1%	0.005%
5/17/2021	Nuveen Asset Management LLC	679,810	$113.71M	0.0%	-4.1%	1.518%
5/17/2021	Thrivent Financial for Lutherans	25,048	$4.19M	0.0%	-34.2%	0.056%
5/17/2021	Atom Investors LP	4,049	$0.68M	0.1%	-63.7%	0.009%
5/17/2021	Centiva Capital LP	1,207	$0.20M	0.0%	N/A	0.003%
5/17/2021	Goldman Sachs Group Inc.	323,365	$54.09M	0.0%	-16.4%	0.722%
5/14/2021	Ontario Teachers Pension Plan Board	3,838	$0.64M	0.0%	-45.9%	0.009%
5/14/2021	Profund Advisors LLC	10,239	$1.71M	0.1%	-10.2%	0.023%
5/14/2021	New York Life Investments Alternatives	4,309	$0.72M	0.5%	N/A	0.010%
5/14/2021	Eqis Capital Management Inc.	3,788	$0.63M	0.0%	-14.9%	0.008%
5/14/2021	Donoghue Forlines LLC	3,454	$0.58M	0.1%	-13.1%	0.008%
5/14/2021	AGF Investments LLC	3,784	$0.63M	0.1%	-33.2%	0.008%
5/14/2021	Public Employees Retirement System of Ohio	32,975	$5.52M	0.0%	+26.7%	0.074%
5/14/2021	AGF Investments Inc.	1,116	$0.19M	0.0%	-19.4%	0.002%
5/14/2021	Weiss Multi Strategy Advisers LLC	18,081	$3.02M	0.1%	-2.6%	0.040%
5/14/2021	Lazard Asset Management LLC	304,323	$50.90M	0.1%	+23.8%	0.679%
5/14/2021	Dimensional Fund Advisors LP	753,983	$126.11M	0.0%	-14.9%	1.683%
5/14/2021	Brandes Investment Partners LP	18,389	$3.04M	0.1%	-43.5%	0.041%
5/14/2021	Capital Fund Management S.A.	12,765	$2.14M	0.0%	N/A	0.028%
5/14/2021	APG Asset Management N.V.	14,600	$2.08M	0.0%	N/A	0.033%
5/14/2021	Assetmark Inc.	190,422	$31.85M	0.2%	+1.7%	0.425%

Data available starting January 2016

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Today's Range

Now: $180.66

$177.82

$181.21

50 Day Range

MA: $181.71

$170.47

$187.65

52 Week Range

Now: $180.66

$98.37

$212.62

Volume

401,733 shs

Average Volume

344,181 shs

Market Capitalization

$8.09 billion

P/E Ratio

19.96

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of United Therapeutics?

United Therapeutics' top insider shareholders include:

Martine A Rothblatt (CEO)
Judy D Olian (Director)
Tommy G Thompson (Director)
Richard Giltner (Director)
Christopher Patusky (Director)
Raymond Dwek (Director)

Who are the major institutional investors of United Therapeutics?

United Therapeutics' top institutional investors include:

Emerald Advisers LLC — 0.42%
Emerald Mutual Fund Advisers Trust — 0.41%
Poplar Forest Capital LLC — 0.40%
Eagle Health Investments LP — 0.22%
New York State Common Retirement Fund — 0.21%
Alliancebernstein L.P. — 0.16%

Which major investors are selling United Therapeutics stock?

In the last quarter, UTHR stock was sold by these institutional investors:

MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income
Emerald Advisers LLC
State of Michigan Retirement System
Cutler Group LP
Hussman Strategic Advisors Inc.
Emerald Mutual Fund Advisers Trust
New England Research & Management Inc.
Dupont Capital Management Corp

In the last year, company insiders that have sold United Therapeutics company stock include:

Martine A Rothblatt (CEO)
Judy D Olian (Director)
Tommy G Thompson (Director)

Which major investors are buying United Therapeutics stock?

Within the last quarter, UTHR stock was purchased by institutional investors including:

Poplar Forest Capital LLC
Eagle Health Investments LP
Oppenheimer Asset Management Inc.
New York State Common Retirement Fund
Clark Capital Management Group Inc.
Chartwell Investment Partners LLC
New Mexico Educational Retirement Board
Veriti Management LLC

Even Utah Is Falling in Love with Psychedelics

From Investing Trends | Ad

Here's how you could get in on the ground floor